As shown in this report, lymphoid-specific TRAF3/BCL2 double-tg mice develop B cell neoplasms, mostly DLBCL and plasma cell neoplasia, with high incidence (approximately 80% of the mice). The gene discussed is BCL2; the disease is B-cell neoplasm.